Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2021-02-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000001184 |
| _version_ | 1818926137013698560 |
|---|---|
| author | Zhi-Mei Zhao Song-Ping Wang Lei Sun You-Xin Ji Pei-Fang Wei |
| author_facet | Zhi-Mei Zhao Song-Ping Wang Lei Sun You-Xin Ji Pei-Fang Wei |
| author_sort | Zhi-Mei Zhao |
| collection | DOAJ |
| first_indexed | 2024-12-20T02:52:20Z |
| format | Article |
| id | doaj.art-299d0e82821b467fada696c002631f5a |
| institution | Directory Open Access Journal |
| issn | 0366-6999 2542-5641 |
| language | English |
| last_indexed | 2024-12-20T02:52:20Z |
| publishDate | 2021-02-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Chinese Medical Journal |
| spelling | doaj.art-299d0e82821b467fada696c002631f5a2022-12-21T19:56:00ZengWolters KluwerChinese Medical Journal0366-69992542-56412021-02-01134337337410.1097/CM9.0000000000001184202102050-00020Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplificationZhi-Mei Zhao0Song-Ping Wang1Lei Sun2You-Xin Ji3Pei-Fang Wei4Department of Oncology, Qingdao Central Hospital, Qingdao University, Qingdao, Shandong 266042, China.Department of Oncology, Qingdao Central Hospital, Qingdao University, Qingdao, Shandong 266042, China.Department of Oncology, Qingdao Central Hospital, Qingdao University, Qingdao, Shandong 266042, China.Department of Oncology, Qingdao Central Hospital, Qingdao University, Qingdao, Shandong 266042, China.Department of Oncology, Qingdao Central Hospital, Qingdao University, Qingdao, Shandong 266042, China.http://journals.lww.com/10.1097/CM9.0000000000001184 |
| spellingShingle | Zhi-Mei Zhao Song-Ping Wang Lei Sun You-Xin Ji Pei-Fang Wei Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification Chinese Medical Journal |
| title | Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification |
| title_full | Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification |
| title_fullStr | Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification |
| title_full_unstemmed | Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification |
| title_short | Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification |
| title_sort | crizotinib plus erlotinib overcomes osimertinib resistance in a seriously ill non small cell lung cancer patient with acquired met amplification |
| url | http://journals.lww.com/10.1097/CM9.0000000000001184 |
| work_keys_str_mv | AT zhimeizhao crizotinibpluserlotinibovercomesosimertinibresistanceinaseriouslyillnonsmallcelllungcancerpatientwithacquiredmetamplification AT songpingwang crizotinibpluserlotinibovercomesosimertinibresistanceinaseriouslyillnonsmallcelllungcancerpatientwithacquiredmetamplification AT leisun crizotinibpluserlotinibovercomesosimertinibresistanceinaseriouslyillnonsmallcelllungcancerpatientwithacquiredmetamplification AT youxinji crizotinibpluserlotinibovercomesosimertinibresistanceinaseriouslyillnonsmallcelllungcancerpatientwithacquiredmetamplification AT peifangwei crizotinibpluserlotinibovercomesosimertinibresistanceinaseriouslyillnonsmallcelllungcancerpatientwithacquiredmetamplification |